International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

Tufts Medical Center and National Health Council Report New… 05/25/2021
[Book Release] Value-Based Drug Pricing Guide on Flawed $500… 03/10/2021
ICER Releases Evidence Report on Multiple Myeloma Therapies 04/05/2021
Matthew McHugh Appointed Director for Health Outcomes and… 02/10/2021
Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020
ICER Adds Members to Three Appraisal Councils to Boost… 03/18/2021
Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020